NCT00133770View on ClinicalTrials.gov

Intravenous (IV) Pantoprazole in Erosive Esophagitis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

March 31, 2007

Conditions
Esophagitis
Interventions
DRUG

pantoprazole

The continuous IV pantoprazole compared to the once a day IV pantoprazole for 72 hours in the treatment of severe erosive esophagitis

Trial Locations (1)

30322

Emory University School of Medicine, Atlanta

All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Emory University

OTHER

NCT00133770 - Intravenous (IV) Pantoprazole in Erosive Esophagitis | Biotech Hunter | Biotech Hunter